
California Drug Rehabs Face the Toughest Commercial Billing Scrutiny in a Decade
California drug rehabs face commercial billing scrutiny from four directions in 2026: pre-payment audits, SB 855 parity-driven review tightening, Marketplace authorization narrowing, and state enforcement around patient brokering. Compliant operators need tighter documentation, defensible coding, and audit-ready records to protect revenue.










